Medtronic acquires cerebrospinal fluid monitoring catheters from Drager.
This article was originally published in The Gray Sheet
MEDTRONIC TO SUBMIT 510(K)s FOR DRAGER CSF CATHETERS by the end of the year, the company predicts. Medtronic announced Aug. 20 that it has acquired three of Drager Medical Electronics' catheter lines used to assess cerebrospinal fluid (CSF) accumulation. Terms of the deal were not disclosed.
You may also be interested in...
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.
Amid several new and updated draft guidance documents and the potential approach of the first approval, interchangeability continues to be a buzzword in US biosimilars. AbbVie has projected that two Humira (adalimumab) biosimilars will hold the designation when they launch in 2023.